Search Results

There are 4234 results for: content related to: Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. Absence of a Pharmacokinetic Interaction Between Entecavir and Adefovir

    The Journal of Clinical Pharmacology

    Volume 47, Issue 10, October 2007, Pages: 1327–1334, Mr Marc Bifano, Dr Jing-He Yan, Dr Robert A. Smith, Dr Duxi Zhang, Dr Dennis M. Grasela and Dr Frank LaCreta

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007304780

  3. Discovery and Development of Entecavir

    Antiviral Drugs: From Basic Discovery through Clinical Trials

    Richard Wilber, Bruce Kreter, Marc Bifano, Stephanie Danetz, Lois Lehman-McKeeman, Daniel J. Tenney, Nicholas Meanwell, Robert Zahler, Helena Brett-Smith, Pages: 401–416, 2011

    Published Online : 20 JUN 2011, DOI: 10.1002/9780470929353.ch28

  4. Entecavir Pharmacokinetics, Safety, and Tolerability After Multiple Ascending Doses in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 46, Issue 11, November 2006, Pages: 1250–1258, Dr Jing-He Yan, Mr Marc Bifano, Mr Steven Olsen, Dr Robert A. Smith, Dr Duxi Zhang, Dr Dennis M. Grasela and Dr Frank LaCreta

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006293304

  5. You have free access to this content
    Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen–positive chronic hepatitis B

    Hepatology

    Volume 63, Issue 2, February 2016, Pages: 377–387, Maureen M. Jonas, Mei-Hwei Chang, Etienne Sokal, Kathleen B. Schwarz, Deirdre Kelly, Kyung Mo Kim, Simon C. Ling, Philip Rosenthal, Dumitru Oraseanu, Laurie Reynolds, Alexandra Thiry and Peter Ackerman

    Version of Record online : 16 OCT 2015, DOI: 10.1002/hep.28015

    Corrected by:

    Corrections: Correction

    Vol. 65, Issue 4, 1427, Version of Record online: 3 MAR 2017

  6. You have free access to this content
    Entecavir treatment for up to 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 422–430, Ting-Tsung Chang, Ching-Lung Lai, Seung Kew Yoon, Samuel S. Lee, Henrique Sergio M. Coelho, Flair Jose Carrilho, Fred Poordad, Waldemar Halota, Yves Horsmans, Naoky Tsai, Hui Zhang, Daniel J. Tenney, Ricardo Tamez and Uchenna Iloeje

    Version of Record online : 4 JAN 2010, DOI: 10.1002/hep.23327

  7. A meta-analysis comparing the efficacy of entecavir and tenofovir for the treatment of chronic hepatitis B infection

    The Journal of Clinical Pharmacology

    Volume 55, Issue 3, March 2015, Pages: 288–297, Shan-Ru Zuo, Xiao-Cong Zuo, Chun-Jiang Wang, Yu-Tao Ma, Hao-Ye Zhang, Zuo-Jun Li, Li-Ying Song, Zhen-Zhen Deng and Shi-Kun Liu

    Version of Record online : 20 NOV 2014, DOI: 10.1002/jcph.409

  8. Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: Histological improvement or entecavir resistance?

    Journal of Gastroenterology and Hepatology

    Volume 24, Issue 3, March 2009, Pages: 429–435, Yoshiyuki Suzuki, Fumitaka Suzuki, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Yuzo Miyakawa and Hiromitsu Kumada

    Version of Record online : 15 FEB 2009, DOI: 10.1111/j.1440-1746.2008.05760.x

  9. Do different lamivudine-resistant hepatitis B genotypes carry the same risk of entecavir resistance?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 26–33, Guan Huei Lee, Myat Oo Aung, Yock Young Dan, Yin Mei Lee, Belinda Mak, How Cheng Low, Kieron Lim, Maung Aye Thwin, Poh Seng Tan and Seng Gee Lim

    Version of Record online : 28 SEP 2012, DOI: 10.1002/jmv.23392

  10. You have free access to this content
    Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function

    Hepatology

    Volume 50, Issue 6, December 2009, Pages: 2001–2006, Christian M. Lange, Jörg Bojunga, Wolf Peter Hofmann, Katrin Wunder, Ulrike Mihm, Stefan Zeuzem and Christoph Sarrazin

    Version of Record online : 29 SEP 2009, DOI: 10.1002/hep.23346

  11. Antiviral effect of entecavir in nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy

    Journal of Viral Hepatitis

    Volume 21, Issue 8, August 2014, Pages: e55–e64, Chien-Hung Chen, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu and Chuan-Mo Lee

    Version of Record online : 28 APR 2014, DOI: 10.1111/jvh.12239

  12. You have free access to this content
    HBV Trials and Treatments

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 647A–705A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26856

  13. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  14. Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort

    Journal of Viral Hepatitis

    Volume 22, Issue 2, February 2015, Pages: 120–127, G. V. Papatheodoridis, S. Manolakopoulos, G. Touloumi, G. Nikolopoulou, M. Raptopoulou-Gigi, C. Gogos, I. Vafiadis-Zouboulis, D. Karamanolis, A. Chouta, A. Ilias, C. Drakoulis, K. Mimidis, I. Ketikoglou, E. Manesis, M. Mela, G. Hatzis, G. N. Dalekos and for the HepNet.Greece Study Group

    Version of Record online : 15 JUL 2014, DOI: 10.1111/jvh.12283

  15. You have free access to this content
    Cost-Effectiveness of Nucleoside Analog Therapy for Hepatitis B in China: A Markov Analysis

    Value in Health

    Volume 13, Issue 5, August 2010, Pages: 592–600, Bin Wu, Te Li, Huafeng Chen and Jinfang Shen

    Version of Record online : 30 APR 2010, DOI: 10.1111/j.1524-4733.2010.00733.x

  16. You have free access to this content
    Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

    Hepatology

    Volume 52, Issue 3, September 2010, Pages: 886–893, Ting-Tsung Chang, Yun-Fan Liaw, Shun-Sheng Wu, Eugene Schiff, Kwang-Hyub Han, Ching-Lung Lai, Rifaat Safadi, Samuel S. Lee, Waldemar Halota, Zachary Goodman, Yun-Chan Chi, Hui Zhang, Robert Hindes, Uchenna Iloeje, Suzanne Beebe and Bruce Kreter

    Version of Record online : 1 JUN 2010, DOI: 10.1002/hep.23785

  17. Entecavir: A New Nucleoside Analog for the Treatment of Chronic Hepatitis B Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 12, December 2006, Pages: 1745–1757, Keri A. Sims and Abigail M. Woodland

    Version of Record online : 11 JAN 2012, DOI: 10.1592/phco.26.12.1745

  18. You have full text access to this OnlineOpen article
    Safety and efficacy of two-step peginterferon α-2a treatment in patients of chronic hepatitis B with acute exacerbation

    Journal of Viral Hepatitis

    Volume 19, Issue 3, March 2012, Pages: 161–172, C.-C. Chen, P.-C. Wang, H.-W. Chang and C.-F. Chen

    Version of Record online : 4 JUL 2011, DOI: 10.1111/j.1365-2893.2011.01469.x

  19. You have free access to this content
    Entecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologic, biochemical, and serology outcomes through 96 weeks

    Hepatology

    Volume 48, Issue 1, July 2008, Pages: 99–108, Morris Sherman, Cihan Yurdaydin, Halis Simsek, Marcelo Silva, Yun-Fan Liaw, Vinod K. Rustgi, Hoel Sette, Naoky Tsai, Daniel J. Tenney, James Vaughan, Bruce Kreter and Robert Hindes

    Version of Record online : 8 JUN 2008, DOI: 10.1002/hep.22323

  20. You have free access to this content
    Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis

    Hepatology

    Volume 58, Issue 5, November 2013, Pages: 1537–1547, Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Christy Wing-Hin Mak, Stanley King-Yeung Lee, Zoe Man-Yi Ip, Andrew Ting-Ho Lam, Henry Wing-Hang Iu, Joyce May-Sum Leung, Jennifer Wing-Yan Lai, Angeline Oi-Shan Lo, Hoi-Yun Chan and Vincent Wai-Sun Wong

    Version of Record online : 30 SEP 2013, DOI: 10.1002/hep.26301